Page 2 of 4
Progress in the Implementation of Label-Free Detection - part 1: cell-based assays. Summer 08Summer 08 Progress made in the use of impedance and optical grating technologies for label-free detection of cell-based assays where examined in HTStec’s recent Cell-Based Label-Free Detection Tr...
|
Integrating HTS and fragment-based drug discovery. Summer 08Summer 2008 High-Throughput Screening and Fragment Based Drug Discovery have been considered as alternative approaches to drug discovery for enzyme targets
|
Screening the Human Kinome, Expectations Met or Promises Pending? Summer 08Summer 2008 Protein kinases are important targets in drug discovery programmes aimed at treating cancer, autoimmune disorders, diabetes and neurological disorders.
|
High throughput screening in academia drug discovery initiatives at the University of Kansas Fall 08By Dr P McDonald, Dr Roy, Byron Taylor, Ashleigh Price, Dr Sittampalam, Dr Scott Weir, Dr Chaguturu Academia has historically been involved in exploring the fundamental aspects of the disease targets and in developing tool molecules to better understand the genetic, biological and bioch...
|
Ho Low Can You Go? Fall 08By Dr John Todd and Dr Sara J. Agee Proteins are the machinery that drive most biological processes; however, measuring their concentrations at low levels has been historically impeded by a lack of appropriately sensitive t...
|
Kinase Screening and Profiling - spoilt for choice. Winter 06By Dr John Comley Overall, the end user is spoilt for choice with the range of alternative offerings, methodologies and approaches currently available for kinase screening and profiling.
|
Page 2 of 4
|
|
